PHOSPHONORTONIC DIN 00170852
Status: Cancelled Post Market
Holder: PFIZER CANADA INC ANIMAL HEALTH GROUP
Health Canada record
| Active ingredient(s) | SODIUM P-DIMETHYL AMINO ORTHOLOLUENE PHOSPH TRIHYD 100 MG; VITAMIN D3 (VITAMIN D3) 4000 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intravenous; Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1958 |
| Current status date | 17-Jul-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM P-DIMETHYL AMINO ORTHOLOLUENE PHOSPH TRIHYD
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00712663 | D PHOS INJ | LANGFORD | Liquid | SODIUM P-DIMETHYL AMINO ORTHOLOLUENE PHOSPH TRIHYD 100 MG; VITAMIN D3 4000 UNIT | Cancelled Post Market |
| 00338133 | PHOSPHONORTONIC INJ 10% | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | SODIUM P-DIMETHYL AMINO ORTHOLOLUENE PHOSPH TRIHYD 100 MG | Cancelled Post Market |